Lord, Abbett & Co. LLC Novartis Ag Transaction History

Lord, Abbett & Co. LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$80.93 - $91.1 $49.8 Million - $56.1 Million	-615,632 Closed	0 $0
Q1 2020 May 14, 2020	SELL	$70.67 - $99.01 $3.07 Million - $4.3 Million	-43,381 Reduced 6.58%	615,632 $50.8 Million
Q4 2019 Feb 14, 2020	SELL	$84.35 - $95.37 $3.47 Million - $3.93 Million	-41,193 Reduced 5.88%	659,013 $62.4 Million
Q3 2019 Nov 14, 2019	SELL	$85.54 - $94.26 $1.85 Million - $2.04 Million	-21,615 Reduced 2.99%	700,206 $60.8 Million
Q2 2019 Aug 14, 2019	BUY	$75.4 - $92.8 $30.5 Million - $37.5 Million	404,321 Added 127.35%	721,821 $65.9 Million
Q1 2019 May 15, 2019	SELL	$75.32 - $86.15 $2.19 Million - $2.5 Million	-29,070 Reduced 8.39%	317,500 $30.5 Million
Q4 2018 Feb 14, 2019	SELL	$73.66 - $82.02 $1.5 Million - $1.67 Million	-20,400 Reduced 5.56%	346,570 $29.7 Million
Q3 2018 Nov 14, 2018	SELL	$66.94 - $77.43 $25.2 Million - $29.1 Million	-376,018 Reduced 50.61%	366,970 $31.6 Million
Q2 2018 Aug 14, 2018	SELL	$64.91 - $73.36 $28.2 Million - $31.9 Million	-434,176 Reduced 36.88%	742,988 $56.1 Million
Q1 2018 May 15, 2018	BUY	$70.39 - $84.15 $24.7 Million - $29.6 Million	351,200 Added 42.52%	1,177,164 $95.2 Million
Q4 2017 Feb 14, 2018	BUY	$72.33 - $77.64 $9.21 Million - $9.89 Million	127,329 Added 18.23%	825,964 $69.3 Million
Q3 2017 Nov 14, 2017	BUY	$74.14 - $77.27 $25.5 Million - $26.6 Million	344,304 Added 97.17%	698,635 $60 Million
Q2 2017 Aug 14, 2017	BUY	N/A	354,331	354,331 $29.6 Million

1,435

133M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $224B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Lord, Abbett & Co. LLC, based on Form 13F filings with the SEC.

Stay updated on Lord, Abbett & Co. LLC with notifications on news.